Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reinvent Biologics is a regenerative medicine company focused on providing innovative biologic solutions for the orthopedic and spine surgical communities. The company’s product portfolio includes demineralized bone matrix (DBM), amniotic tissue, and cellular bone grafts designed to enhance bone healing and tissue regeneration. By leveraging advanced processing technologies, Reinvent Biologics delivers high-performance allografts and synthetics that meet the rigorous demands of surgeons and improve patient outcomes. Headquartered in Scottsdale, Arizona, the firm emphasizes clinical efficacy and ease of use across its diverse range of regenerative products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reinvent Biologics.